Wehrmann T, Martchenko K, Nakamura M, Riphaus A, Stergiou N
Department of Internal Medicine I (Gastroenterology and Interventional Endoscopy), Klinikum Hannover-Siloah, Roesebeckstrasse 15, 30449 Hannover, Germany.
Endoscopy. 2004 Sep;36(9):802-7. doi: 10.1055/s-2004-825814.
The introduction of endoscopic ultrasound (EUS) and endoscopic mucosal resection has offered a new alternative to simple observation or surgical resection for the management of esophageal submucosal tumors.
During a 4-year period, endoscopic resection was attempted in 20 consecutive patients (nine women, 11 men; mean age 52 +/- 10 years) with esophageal submucosal tumors < 4 cm in size, confirmed by endoscopy and miniprobe EUS (20 MHz). The mean tumor diameter was 17 +/- 8 mm (8 - 34 mm). Prior EUS-guided cytological examination revealed benign tumors in 11 patients; however, endoscopic resection was attempted in most patients for diagnostic purposes also. Several patients were symptomatic (retrosternal pain, n = 4; dysphagia, n = 4; recurrent bleeding, n = 2) but most tumors had been detected incidentally.
In the majority of patients the tumor was ligated with a rubber band and then resected with a snare (n = 11), and in the others simple snare resection ("lift-and-cut," n = 7) or cap resection (n = 2) was done. A macroscopically complete endoscopic resection was achieved in 19/20 patients, and the remaining patient was managed surgically. Endoscopic hemostasis was necessary (and successful) in eight patients (40 %), but blood transfusion was not required. No other side effects occurred. Histological examination revealed granular cell tumor in 12 patients, leiomyoma in six patients, and a lipoma and stromal tumor in one patient each. Histologically, all tumors were judged to be benign and a microscopically complete resection (R0) was achieved in all patients, with the exception of the one patient with a stromal tumor. Thus, surgical resection was necessary in only two of the 20 patients (10 %). During the median prospective follow-up of 12 months no tumor recurrence was detected in any patient.
Endoscopic resection of esophageal submucosal tumors is safe and effective. The probability of achieving curative resection (R0 resection, histologically benign) is high especially if the tumors are smaller in size (< 4 cm).
内镜超声(EUS)及内镜黏膜切除术的引入,为食管黏膜下肿瘤的治疗提供了一种新的选择,替代了单纯观察或手术切除。
在4年期间,对连续20例经内镜及微型探头EUS(20MHz)确诊的食管黏膜下肿瘤大小<4cm的患者(9例女性,11例男性;平均年龄52±10岁)尝试进行内镜切除。肿瘤平均直径为17±8mm(8 - 34mm)。术前EUS引导下细胞学检查显示11例患者为良性肿瘤;然而,大多数患者也因诊断目的而尝试进行内镜切除。部分患者有症状(胸骨后疼痛,4例;吞咽困难,4例;反复出血,2例),但大多数肿瘤是偶然发现的。
大多数患者先用橡皮筋结扎肿瘤,然后用圈套器切除(11例),其他患者则进行单纯圈套器切除(“提起并切除",7例)或套帽切除(2例)。20例患者中有19例实现了宏观上的内镜完整切除,其余1例患者接受了手术治疗。8例患者(40%)需要(且成功进行了)内镜止血,但无需输血。未发生其他副作用。组织学检查显示12例患者为颗粒细胞瘤, 6例为平滑肌瘤,1例为脂肪瘤,1例为间质瘤。组织学上,所有肿瘤均判定为良性,除1例间质瘤患者外,所有患者均实现了微观上的完整切除(R0)。因此,20例患者中仅2例(10%)需要手术切除。在为期12个月的中位前瞻性随访期间,未发现任何患者肿瘤复发。
食管黏膜下肿瘤的内镜切除安全有效。实现根治性切除(R0切除,组织学良性)的概率很高,尤其是肿瘤较小(<4cm)时。